MOMO'S BREAKOUT BOARD

[TacoTuesdayz]

$LUDG a USA based biotechnology company is pleased to announce Revealia™, which is set to become the world's most convenient cancer screening tool. This simple mail-order non-invasive cheek swab has the potential to save lives by detecting early signs of cancer.

At the heart of Revealia™ is the Revealia Inflammatory Index (RII), a sophisticated method for quantifying cancer risk. The RII leverages cutting-edge artificial intelligence to analyze mRNA-based genetic signals associated with the presence of cancer.

This proprietary technology was developed by Dr. Kyle Ambert, PhD, Director of Data Science at Nike's Consumer Data Science Division. Our AI technology employs machine learning algorithms that continuously update and improve as new patient data is received. This approach allows for ongoing refinement of our cancer detection capabilities.

Key features of our AI approach include:

Optimization of the trade-off between sensitivity and specificity

Continuous learning from an expanding dataset

Analysis of mRNA samples from over 40 multipurpose medical clinics across the United States

Looking Ahead

"Ludwig has uncovered game-changing mRNA-based genetic signals associated with the presence of cancer," stated Marvin S. Hausman, MD, CSO. "As we prepare to launch Revealia™, we're excited about the potential impact of our AI-driven approach for early cancer detection."

Ludwig Enterprises continues to advance its mission of providing accessible, accurate, and non-invasive cancer screening tools to improve public health.

$LUDG Press Release out | "Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology"https://t.co/vYRLO9fvGn

— Ludwig Enterprises Inc. | OTC:LUDG (@LUDG_inc) September 24, 2024